5838 dni has been researched along with tetracenomycin x in 1 studies
| Studies (5838 dni) | Trials (5838 dni) | Recent Studies (post-2010) (5838 dni) | Studies (tetracenomycin x) | Trials (tetracenomycin x) | Recent Studies (post-2010) (tetracenomycin x) |
|---|---|---|---|---|---|
| 20 | 0 | 8 | 9 | 0 | 7 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alferova, VA; Biryukov, MV; Korshun, VA; Maviza, TP; Osterman, IA; Polshakov, VI; Sergiev, PV; Zakalyukina, YV | 1 |
1 other study(ies) available for 5838 dni and tetracenomycin x
| Article | Year |
|---|---|
Characterization of a novel natural tetracenomycin reveals crucial role of 4-hydroxy group in ribosome binding.
Topics: Anti-Bacterial Agents; Binding Sites; Protein Biosynthesis; Ribosomes | 2023 |